Table 3.
Characteristics of the included studies comparing survivor and non-survivor COVID-19 patients.
| Author | Year | Country | Participants (male) |
Median/mean age (IQR/SD) | Comorbidities (n) |
AGR mean in non-survivor patients | AGR mean in survivor patients | Cut-off | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes Mellitus | Hypertension | Obesity | ||||||||
| Wei Y et al. | 2020 | China | 112 (73) | 61 (14.9) | 21 | 40 | NR | 1.2 (0.2) | 1.5 (0.3) | NR |
| Wang Xue et al. | 2020 | China | 131 (56) | 64 (56–71) | 28 | 52 | NR | 0.9 (0.17) | 1.27 (0.25) | NR |
| Caillon A et al. | 2021 | China | 157 (75) | 64 (46–76) | 24 | 55 | NR | 1.09 (0.22) | 1.34 (0.26) | NR |
| Wang Kun et al. | 2020 | China | 296 (140) | 47.32 (14.95) | 30 | 42 | NR | 1.2 (0.3) | 1.6 (0.4) | NR |
| Elavarasi A et al. | 2021 | India | 2017 (1320) | 47.4 (17.6) | 437 | 457 | NR | 1.3 (0.29) | 1.52 (0.22) | NR |
| Huang Wei et al. | 2020 | China | 2240 (1136) | 64 (52–71) | NR | NR | NR | 0.85 (0.17) | 1.16 (0.31) | NR |
NR: NOT REPORTED.